Oncology

Defying cancer

Our defiant goal is to reverse the cancer mortality trend. We’re doing this through a comprehensive pipeline that addresses the hallmarks of cancer. With an emphasis on immuno-oncology and antibody drug conjugates (ADCs), we are unleashing the power of our own immune systems and targeting tumors with lethal drugs.




Our Pipeline

Oncology

Phase 1

Phase 1

  • MEDI-565 solid tumours
  • MEDI0562 solid tumours
  • MEDI0680 solid tumours
  • MEDI1873 solid tumours
  • MEDI3726 prostate cancer
  • MEDI4276 solid tumours
  • MEDI5083 solid tumours
  • MEDI9197 solid tumours
  • MEDI9447 solid tumours
  • durvalumab + AZD1775 solid tumours
  • durvalumab + Iressa NSCLC
  • durvalumab + MEDI0562 solid tumours
  • durvalumab + MEDI9447 solid tumours
  • durvalumab + dabrafenib + trametinib melanoma
  • durvalumab + monalizumab solid tumours
  • durvalumab + selumetinib solid tumours
  • durvalumab + tremelimumab solid tumours
  • durvalumab or durvalumab + (tremelimumab or AZD9150) diffuse large B-cell lymphoma
  • tremelimumab + MEDI0562 solid tumours

Phase 2

Phase 2

  • MEDI-573 metastatic breast cancer
  • durvalumab solid tumours
  • durvalumab + AZD5069 durvalumab + AZD9150 HNSCC
  • durvalumab + MEDI0680 solid tumours
  • durvalumab + tremelimumab hepatocellular carcinoma (liver cancer)
  • durvalumab + tremelimumab gastric cancer

Phase 3

Phase 3

  • durvalumab ≥2nd-line advanced bladder cancer
  • durvalumab PACIFIC stage III NSCLC
  • durvalumab PEARL 1st-line NSCLC
  • durvalumab + tremelimumab ARCTIC 3rd-line NSCLC
  • durvalumab + tremelimumab DANUBE 1st-line bladder
  • durvalumab + tremelimumab EAGLE 2nd-line SCCHN
  • durvalumab + tremelimumab KESTREL 1st-line SCCHN
  • durvalumab + tremelimumab MYSTIC 1st-line NSCLC
  • durvalumab + tremelimumab NEPTUNE 1st-line NSCLC
  • durvalumab + tremelimumab CASPIAN 1st-line SCLC
  • moxetumomab pasudotox PLAIT hairy cell leukaemia

Oncology News

Join us at MedImmune

Our Great Place to Work strategic initiative offers a dynamic environment that fosters collaboration and innovation. We attract top minds, and we do what it takes to nurture and build talent.